This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...